Table 2.
Association of symptom cluster (arthralgia, fatigue, and insomnia) with inflammatory biomarkers
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Coefficient (95 % CI) | p value | Coefficient (95 % CI) | p value | |
CRP | 117.3 (49.3–185.3) | 0.001 | 93.1 (25.1–161.1) | 0.008 |
Eotaxin | 87.3 (40.8–133.7) | <0.001 | 79.9 (32.5–127.2) | 0.001 |
MCP-1 | 178 (63–293.2) | 0.003 | 151.2 (32.7–269.8) | 0.013 |
VDBP | 21,530.8 (8088.4–34,973.2) | 0.002 | 19,422 (5500.5–33,344) | 0.006 |
Data shown are results of multivariate linear regression analyses controlled for race, body mass index, chemotherapy status, non-steroidal anti-inflammatory drug use, and age
CI confidence interval, CRP C-reactive protein, MCP-1 monocyte chemoattractant protein 1, VDBP vitamin D–binding protein